Synovis Life Tech (SYNO)

Synovis Life Technologies, Inc., a medical device company, engages in the development, manufacture, and marketing of biological and mechanical products used by surgical specialties for the repair and reconstruction of soft tissue damaged or destroyed by disease or injury. The company’s products include implantable biomaterials for soft tissue repair, devices for microsurgery, and surgical tools. Its biomaterial products comprise Peri-Strips, which are biomaterial stapling buttresses used as reinforcement at the surgical staple line to reduce fatal leaks; Tissue-Guard that is used to repair and replace damaged tissue in cardiac, vascular, thoracic, and neurologic procedures; Veritas for use in surgery to repair soft tissue; and Ortho & Wound products for use in various orthopedic applications, including rotator cuff and Achilles tendon repair, as well as for the treatment of chronic wounds, such as diabetic foot ulcers and pressure ulcers. The company’s devices for microsurgery comprise Microvascular Anastomotic Coupler, which enables microsurgeons in various surgical specialties to perform anastomotic microsurgical procedures, including plastic and reconstructive, head and neck, and orthopedic and hand; GEM Microclip, a hemostatic clip designed to securely ligate vessels and provide for atraumatic occlusion; and Neurotube, a device designed to assist in the reconnection of severed nerves. It also distributes various product lines for companies in the microsurgery market. Synovis Life Technologies sells its products through independent distributors and direct sales representatives primarily in the United States, Europe, Canada, Asia, and the Pacific region. The company was formerly known as Bio-Vascular, Inc. and changed its name to Synovis Life Technologies, Inc. in May 2002. The company was founded in 1985 and is headquartered in St. Paul, Minnesota. Synovis Life Technologies Inc. operates as a subsidiary of Baxter International Inc.